Protective effect of high mobility group box-1 silence on diabetic retinopathy: an in vivo study

被引:0
|
作者
Jiang, Ning [1 ]
Chen, Xiaolong [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Ophthalmol, 36 Sanhao St, Shenyang, Liaoning, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2017年 / 10卷 / 08期
基金
中国国家自然科学基金;
关键词
High mobility group box-1; retinal endotheliocyte injury; high concentration of glucose; MAPK; NF-kappa B; diabetic retinopathy; ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC TARGET; RECEPTOR; 4; HMGB1; CELL; CONTRIBUTES; INHIBITION; DIFFERENTIATION; DYSFUNCTION; ACTIVATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To explore the effects of HMGB1 silence on cell apoptosis, inflammatory response and endothelial permeability barrier. Methods: Retinal tissues were isolated from 8 week-old SD rats and cells were cultured and identified. Effects of HMGB1 silence were detected by qRT-PCR and Western blot. Proliferation capability of cells was detected by MTT assay and LDH activity assays. Cell apoptosis was analyzed by flow cytometry, Hoechst staining and Caspase-3 activity assay. Furthermore, concentrations of VEGF, ICAM-1, VCAM-1, TNF-alpha and MCP-1 in the cell media were measured. Results: Results of our study showed that high concentration of glucose caused increased cell apoptosis and inflammatory response, and also influenced the endothelial permeability barrier. Whereas, these damaging effects of high concentration of glucose could be relieved by HMGB1 silence. Conclusion: The present study indicates that HMGB silence is a promising therapeutic option for diabetic retinopathy, and also provides theoretical basis for further exploration of diabetic retinopathy treatment.
引用
收藏
页码:8148 / 8160
页数:13
相关论文
共 50 条
  • [21] High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina
    Abu El-Asrar, Ahmed M.
    Mohammad, Ghulam
    Nawaz, Mohammad Imtiaz
    Siddiquei, Mohammad Mairaj
    CURRENT EYE RESEARCH, 2015, 40 (11) : 1141 - 1152
  • [22] High-mobility group box-1 regulates the expression of matrix metalloproteinase-9 in diabetic retina
    Mohammad, Ghulann
    Siddiquei, Mohammad Mairaj
    Alam, Kaiser
    Nawaz, Mohammad Imtiaz
    Mousa, Ahmed
    Opdenakker, Ghislain
    Abu El-Asrar, Ahmed M.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 828 - 840
  • [23] The role of high mobility group box-1 on the development of diabetes complications: A plausible pharmacological target
    Ngcobo, Nokwanda N.
    Sibiya, Ntethelelo H.
    DIABETES & VASCULAR DISEASE RESEARCH, 2024, 21 (05)
  • [24] Investigation of Chronic Pain for the Development of Novel Analgesics Focusing on High Mobility Group Box-1
    Nakamura, Yoki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2024, 144 (01): : 15 - 18
  • [25] High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
    Vijayakumar, Eyaldeva C.
    Bhatt, Lokesh Kumar
    Prabhavalkar, Kedar S.
    CURRENT DRUG TARGETS, 2019, 20 (14) : 1474 - 1485
  • [26] Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases
    Kumar, Vishal
    Kumar, Puneet
    INFLAMMOPHARMACOLOGY, 2025, 33 (02) : 703 - 727
  • [27] Emerging Roles of High-mobility Group Box-1 in Liver Disease
    Wang, Lu
    Dong, Zhiwei
    Zhang, Yeqiong
    Peng, Liang
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2024, 12 (12) : 1043 - 1056
  • [28] The mechanism of high-mobility group box-1 protein and its bidirectional regulation in tumors
    Tian, Zhongjia
    Zhu, Lin
    Xie, Yutong
    Hu, Huan
    Ren, Qunli
    Liu, Jianguo
    Wang, Qian
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (03): : 477 - 485
  • [29] High mobility group box-1 levels may be associated with disease activity of Behcet's disease
    Donmez Guler, Dilara
    Kelesoglu Dincer, Ayse Bahar
    Karahan, Zeynep Ceren
    Guler, Hasan Selim
    Yayla, Mucteba Enes
    Sezer, Serdar
    Aydemir Guloksuz, Emine Gozde
    Okatan, Ilyas Ercan
    Torgutalp, Murat
    Sahin Eroglu, Didem
    Yuksel, Mehmet Levent
    Turgay, Tahsin Murat
    Kinikli, Gulay
    Ates, Askin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (05) : 2690 - 2697
  • [30] High mobility group box 1 in diabetic nephropathy (Review)
    Shi, Haitao
    Che, Yingqi
    Bai, Lin
    Zhang, Jinling
    Fan, Jingxu
    Mao, Huiling
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (03) : 2431 - 2433